—Mkt Cap: —P/E: —
MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products consists of ExPERT ATx, a static electroporation instrume…
Industry Peers
Health Care Technologyloading…
Indicators:|
Key Statistics
Company
Market Cap—
Enterprise Value24.18M USD
Revenue (TTM)32.29M USD
Gross Profit26.80M USD
Net Income (TTM)-44.63M USD
Revenue/Share0.3030 USD
Last Price—
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees91
CountryUS
SectorHealth Care
IndustryHealth Care Technology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-4.26
PEG—
EV/EBITDA-0.71
EV/Revenue0.75
P/S3.52
P/B0.68
EPS (TTM)-0.36
EPS (Forward)-0.25
52W Range
—
52W High—
52W Low—
Profitability
Gross Margin81.16%
Oper. Margin-64.09%
EBITDA Margin-105.80%
Profit Margin-135.14%
ROE-26.02%
ROA-22.04%
Growth
Revenue Growth-7.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF-34.41M USD
CapEx (TTM)1.77M USD
FCF Margin-43.76%
FCF Yield—
Net Debt-89.37M USD
Net Debt/EBITDA2.62
Balance Sheet
Debt/Equity0.10
Current Ratio12.04
Quick Ratio10.88
Book Value/Sh1.567 USD
Cash/Share0.9980 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.6 (Buy)
Target (Mean)4.107 USD
Target Range2.430 USD – 5.000 USD
# Analysts4
Ownership
Shares Out.107.12M
Float97.77M
Insiders1.37%
Institutions67.93%
Short Interest
Short Ratio6.7d
Short % Float4.94%
Short % Out.4.90%
Shares Short5.24M
Short (prev mo.)5.55M
Technical
SMA 500.8374 USD
SMA 2001.237 USD
Beta1.57
S&P 52W Chg28.31%
Avg Vol (30d)—
Avg Vol (10d)1.59M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—